Jing Zhang

US Patent:

8019838, Sep 13, 2011

Filed:

May 21, 2008

Appl. No.:

12/124560

Inventors:

Michael Zhihe Z Jiang - Lake in the Hills IL, US
Yan Liu - Hanover Park IL, US
John C. Strassner - North Barrington IL, US
Jing Zhang - Schaumburg IL, US

Assignee:

Motorola Solutions, Inc. - Schaumburg IL

International Classification:

G06F 15/177

US Classification:

709221, 709224, 370225

Abstract:

A system, method, and information processing system for managing a configuration of a network device. A current state associated with at least one network device () is determined (). A set of commands () available for the current state of the network device () is retrieved (). A next state associated with a current command is determined () for each command in the set of commands (). A transition from the current state to the next state is created () in response to determining a next state associated with a current command. A transition is determined to have been created for each command in the set of commands (). An extended finite state machine () is created that includes at least the current state, the next state, and the transition for each of the commands in the set of commands ().

US Patent:

8505047, Aug 6, 2013

Filed:

Nov 20, 2010

Appl. No.:

12/951014

Inventors:

Yan Liu - Hanover Park IL, US
Bhavan Ghandhi - Vernon Hills IL, US
Srinivasa C. Samudrala - Richardson TX, US
Kabe Vanderbaan - Arlington Heights IL, US
Jing Zhang - Hanover Park IL, US

Assignee:

Motorola Solutions, Inc. - Schaumburg IL

International Classification:

H04N 7/10
H04N 7/025

US Classification:

725 35, 725 34, 725 36, 725116, 725146, 705 11, 705 1443

Abstract:

A content provider broadcasts content to subscribers through a content distribution system. The content distribution system operator can capture broadcast content in accordance with policies established by the content provider and make the content available subsequent to the original broadcast in accordance with applicable business policies. Business policies are created by the content provider by modifying template information models which have associated rules. The content distributor stores the business policies and evaluates rules indicated by the business policies against attributes of a content asset to determine availability of the content asset.

US Patent:

20190202832, Jul 4, 2019

Filed:

Sep 15, 2017

Appl. No.:

16/333900

Inventors:

- Altrincham, Cheshire, GB
Janelle Comita-Prevoir - Northborough MA, US
Thomas Francois Durand-Reville - Belmont MA, US
Lise Gauthier - Waltham MA, US
Bill Moss - Prestbury, Cheshire, GB
John O'Donnell - Mattapoisett MA, US
Jan Romero - Arlington MA, US
Ruben Tommasi - Stow MA, US
Jeroen Cunera Verheijen - Westborough MA, US
Frank Wu - Shrewsbury MA, US
Xiaoyun Wu - Westborough MA, US
Jing Zhang - Sudbury MA, US

Assignee:

Entasis Therapeutics Limited - Altrincham, Cheshire

International Classification:

C07D 471/08
C07D 211/78
A61K 31/439
A61K 31/546
A61P 31/04

Abstract:

The present invention is directed to compounds which are beta-lactamase inhibitors. The compounds and their pharmaceutically acceptable salts are useful in combination with beta-lactam antibiotics, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of R, R, R, R, Rand Rare described herein.

US Patent:

20170216295, Aug 3, 2017

Filed:

Jul 27, 2015

Appl. No.:

15/501103

Inventors:

Blaise Lippa - Acton MA, US
Xin Zhang - Belmont MA, US
Jon Christian Baber - Somerville MA, US
Jan Antionette C. Romero - Somerville MA, US
Jing Zhang - Lexington MA, US

Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ

International Classification:

A61K 31/519
C07D 487/04

Abstract:

Provided herein are compounds that inhibit CCR9 receptor function. Also provided herein are methods of treating inflammatory disease in a subject, comprising administering to the subject a compound of the invention. Accordingly, in one aspect, provided herein is a compound of Formula (1) or a pharmaceutically acceptable salt thereof. In another aspect, provided herein is a pharmaceutical composition, comprising a compound of Formula (1), and a pharmaceutically acceptable carrier.

US Patent:

20170014547, Jan 19, 2017

Filed:

Feb 26, 2015

Appl. No.:

15/121734

Inventors:

- Boston MA, US
Jing Zhang - Worcester MA, US

International Classification:

A61L 27/18
A61L 27/54
A61L 27/56
C08G 63/82
A61L 31/14
A61L 31/16
C08G 63/664
A61L 27/58
A61L 31/10

Abstract:

The invention provides a novel approach to controlled delivery of biomolecules (e.g., lipids and proteins) by employing novel amphiphilic polymers that are effective delivery vehicles. These unique amphiphilic polymers may be employed as controlled delivery vehicles or tissue engineering scaffolds wherein the delivery of lipophilic or amphiphilic bioactive molecules can be achieved. An amphiphilic biodegradable polymer platform is disclosed herein for the stable encapsulation and sustained release of biomolecules, such as S1P.